Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

RIBOCICLIB vs RIFABUTIN: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

RIBOCICLIB vs RIFABUTIN: Safety Overview

Metric RIBOCICLIB RIFABUTIN
Total FAERS Reports 27,997 1,586
Deaths Reported 4,501 158
Death Rate 16.1% 10.0%
Hospitalizations 6,700 502
Average Patient Age 60.2 yrs 53.2 yrs
% Female Patients 99.0% 53.1%
FDA Approval Date Mar 13, 2017 Dec 17, 2021
Manufacturer Novartis Pharmaceuticals Corporation REMEDYREPACK INC.
Route ORAL ORAL
Marketing Status Prescription Prescription